DE602004017731D1 - Verfahren zur herstellung von 1-ä(benzimidazol-1-yl)chinolin-8-ylüpiperidin-4-ylaminderivaten - Google Patents

Verfahren zur herstellung von 1-ä(benzimidazol-1-yl)chinolin-8-ylüpiperidin-4-ylaminderivaten

Info

Publication number
DE602004017731D1
DE602004017731D1 DE602004017731T DE602004017731T DE602004017731D1 DE 602004017731 D1 DE602004017731 D1 DE 602004017731D1 DE 602004017731 T DE602004017731 T DE 602004017731T DE 602004017731 T DE602004017731 T DE 602004017731T DE 602004017731 D1 DE602004017731 D1 DE 602004017731D1
Authority
DE
Germany
Prior art keywords
ylipiperidin
chinolin
benzimidazol
preparation
ylamine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004017731T
Other languages
English (en)
Inventor
Norma Jacqueline Tom
David Harold Brown Ripin
Michael James Castaldi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Products Inc
Original Assignee
Pfizer Products Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc filed Critical Pfizer Products Inc
Publication of DE602004017731D1 publication Critical patent/DE602004017731D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Epoxy Compounds (AREA)
DE602004017731T 2003-06-24 2004-06-14 Verfahren zur herstellung von 1-ä(benzimidazol-1-yl)chinolin-8-ylüpiperidin-4-ylaminderivaten Active DE602004017731D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48217603P 2003-06-24 2003-06-24
PCT/IB2004/001983 WO2004113322A1 (en) 2003-06-24 2004-06-14 Processes for the preparation of 1-[(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives

Publications (1)

Publication Number Publication Date
DE602004017731D1 true DE602004017731D1 (de) 2008-12-24

Family

ID=33539339

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004017731T Active DE602004017731D1 (de) 2003-06-24 2004-06-14 Verfahren zur herstellung von 1-ä(benzimidazol-1-yl)chinolin-8-ylüpiperidin-4-ylaminderivaten

Country Status (25)

Country Link
US (2) US7183414B2 (de)
EP (1) EP1641780B1 (de)
JP (1) JP2007516168A (de)
KR (2) KR20070092333A (de)
CN (1) CN100404530C (de)
AR (1) AR044849A1 (de)
AT (1) ATE414077T1 (de)
AU (1) AU2004249511B2 (de)
BR (1) BRPI0411794A (de)
CA (1) CA2529032C (de)
CL (1) CL2004001470A1 (de)
CO (1) CO5650165A2 (de)
DE (1) DE602004017731D1 (de)
DK (1) DK1641780T3 (de)
ES (1) ES2315663T3 (de)
HK (1) HK1089170A1 (de)
IL (1) IL172064A (de)
MX (1) MXPA05014203A (de)
NO (1) NO20060376L (de)
NZ (2) NZ571898A (de)
RU (1) RU2323214C2 (de)
SG (1) SG161745A1 (de)
TW (1) TWI294425B (de)
WO (1) WO2004113322A1 (de)
ZA (1) ZA200509253B (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0411421D0 (en) * 2004-05-21 2004-06-23 Glaxo Group Ltd Novel compounds
US20100016353A1 (en) * 2004-10-07 2010-01-21 Kirk Russell Henne Benzoimidazole derivatives useful as antiproliferative agents
MX2007012393A (es) * 2005-04-05 2008-02-22 Pharmacopeia Inc Derivados de purina e imidazopiridina para la inmunosupresion.
US7504513B2 (en) 2006-02-27 2009-03-17 Hoffman-La Roche Inc. Thiazolyl-benzimidazoles
JP5576370B2 (ja) 2008-08-06 2014-08-20 ファイザー・インク Chk−1阻害剤としての6置換2−ヘテロシクリルアミノピラジン化合物
EP2379543A2 (de) 2008-12-18 2011-10-26 F. Hoffmann-La Roche AG Thiazolyl-benzimidazole
CN101993416B (zh) * 2009-08-27 2013-09-11 中国科学院上海药物研究所 喹啉类化合物、其制备方法、包含该化合物的药物组合物及该化合物的用途
TWI569799B (zh) 2012-09-21 2017-02-11 安羅格製藥股份有限公司 抑制組成型活性磷酸化flt3激酶的方法
US10835525B2 (en) 2012-09-26 2020-11-17 Arog Pharmaceuticals, Inc. Method of inhibiting mutant C-KIT
TWI599356B (zh) 2012-09-26 2017-09-21 安羅格製藥有限責任公司 抑制突變型c-kit的方法
US11642340B2 (en) 2012-09-26 2023-05-09 Arog Pharmaceuticals, Inc. Method of inhibiting mutant C-KIT
BR112015016282A2 (pt) 2013-01-07 2017-07-11 Arog Pharmaceuticals Inc crenolanibe para tratamento de distúrbios proliferativos de flt3 mutado
US10463658B2 (en) 2013-10-25 2019-11-05 Videra Pharmaceuticals, Llc Method of inhibiting FLT3 kinase
EP3359155A4 (de) 2016-11-02 2019-05-22 Arog Pharmaceuticals, Inc. Crenolanib zur behandlung von mutationen im zusammenhang mit flt3-mutierten proliferativen erkrankungen
CN107382984B (zh) * 2017-08-24 2020-07-10 扬州市三药制药有限公司 一种治疗白血病药物的制备方法
CN107382983B (zh) * 2017-08-24 2020-08-07 扬州市三药制药有限公司 一种治疗白血病药物的合成方法
CN110840893A (zh) 2018-12-13 2020-02-28 安罗格制药有限责任公司 含克莱拉尼的药物组合物及其用途
CN109678849A (zh) * 2019-01-16 2019-04-26 北京悦康科创医药科技股份有限公司 一种抗癌药物的制备方法
US11471451B2 (en) 2019-08-19 2022-10-18 Arog Pharmaceuticals, Inc. Uses of crenolanib
CN117447376A (zh) * 2019-12-09 2024-01-26 苏州恩华生物医药科技有限公司 连双环结构sigma-1受体抑制剂
US11713310B2 (en) * 2020-07-20 2023-08-01 Arog Pharmaceuticals, Inc. Crystal forms of crenolanib and methods of use thereof
US11524006B2 (en) 2020-09-17 2022-12-13 Arog Pharmaceuticals, Inc. Crenolanib for treating TRK kinase associated proliferative disorders
US20220079934A1 (en) * 2020-09-17 2022-03-17 Arog Pharmaceuticals, Inc. Crenolanib for treating pain
US11969420B2 (en) 2020-10-30 2024-04-30 Arog Pharmaceuticals, Inc. Combination therapy of crenolanib and apoptosis pathway agents for the treatment of proliferative disorders
CN113683594B (zh) * 2021-09-07 2022-12-27 曲靖师范学院 一种喹啉-苯并咪唑盐类化合物及其合成方法和应用
JP2023063189A (ja) 2021-10-22 2023-05-09 アログ・ファーマシューティカルズ・インコーポレイテッド 以前の治療に対して再発性/不応性のflt3突然変異増殖性障害を治療するためのクレノラニブ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2300119T3 (es) * 1997-02-27 2008-06-01 Takeda Pharmaceutical Company Limited Compuestos de amina, su produccion y su uso como inhibidores de la produccion de beta-amiloide.
UA75055C2 (uk) * 1999-11-30 2006-03-15 Пфайзер Продактс Інк. Похідні бензоімідазолу, що використовуються як антипроліферативний засіб, фармацевтична композиція на їх основі
EP1245390A4 (de) * 1999-12-10 2009-04-01 Fujifilm Corp Tintenstrahldruckkopf und drucker
EP1321454A4 (de) * 2000-09-14 2005-11-02 Kaneka Corp Verfahren zur abtrennung von nitrobenzenesulfonyl
PA8580301A1 (es) * 2002-08-28 2005-05-24 Pfizer Prod Inc Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos

Also Published As

Publication number Publication date
RU2005138367A (ru) 2006-08-10
MXPA05014203A (es) 2006-02-24
US7183414B2 (en) 2007-02-27
HK1089170A1 (en) 2006-11-24
CA2529032C (en) 2009-12-22
CN1809556A (zh) 2006-07-26
EP1641780A1 (de) 2006-04-05
US20050020625A1 (en) 2005-01-27
CA2529032A1 (en) 2004-12-29
CO5650165A2 (es) 2006-06-30
EP1641780B1 (de) 2008-11-12
JP2007516168A (ja) 2007-06-21
KR20070092333A (ko) 2007-09-12
US20070088032A1 (en) 2007-04-19
SG161745A1 (en) 2010-06-29
ATE414077T1 (de) 2008-11-15
NO20060376L (no) 2006-01-24
NZ571898A (en) 2010-01-29
CL2004001470A1 (es) 2005-05-13
AU2004249511B2 (en) 2011-01-20
WO2004113322A1 (en) 2004-12-29
RU2323214C2 (ru) 2008-04-27
AR044849A1 (es) 2005-10-05
KR20060012033A (ko) 2006-02-06
DK1641780T3 (da) 2009-02-02
CN100404530C (zh) 2008-07-23
ES2315663T3 (es) 2009-04-01
TWI294425B (en) 2008-03-11
ZA200509253B (en) 2007-01-31
KR100787649B1 (ko) 2007-12-21
TW200517393A (en) 2005-06-01
AU2004249511A1 (en) 2004-12-29
IL172064A (en) 2011-01-31
BRPI0411794A (pt) 2006-08-08
NZ543714A (en) 2009-06-26

Similar Documents

Publication Publication Date Title
DE602004017731D1 (de) Verfahren zur herstellung von 1-ä(benzimidazol-1-yl)chinolin-8-ylüpiperidin-4-ylaminderivaten
DE60323192D1 (de) Verfahren zur Herstellung von Hydroxyalkylstärkederivaten
DE602004031895D1 (de) Verfahren zur Herstellung von Dichlorpropanol
DE50303749D1 (de) Verfahren zur herstellung von phthalocyaninpigmentzubereitungen
DE60302682D1 (de) Verfahren zur Herstellung von Nanopartikeln
DE602004010234D1 (de) Verfahren zur herstellung von 4-aminodiphenylamin
DE602004024402D1 (de) Verfahren zur herstellung von tetrazolderivaten au
DE602005014280D1 (de) Verfahren zur herstellung von ä1,4,5ü-oxadiazepinderivaten
DE602004005137D1 (de) Verfahren zur Herstellung von Nanopartikeln
DE50311721D1 (de) Verfahren zur Herstellung von Aryl-aminopropanolen
DE60215867D1 (de) Verfahren zur herstellung von penamderivaten aus cephamderivaten
DE60323793D1 (de) Verfahren zur Herstellung von Fluorhalogenethern
DE60233589D1 (de) Verfahren zur herstellung von echinocandinderivaten
DE60330775D1 (de) Verfahren zur Herstellung von Hydroperoxiden
DE60322356D1 (de) Verfahren zur herstellung von 2-aminoindanderivaten
DE60335766D1 (de) Verfahren zur Herstellung von m-Xylylendiamin
DE602004027840D1 (de) Verfahren zur herstellung von thiazolopyrimidinen
DE502005006107D1 (de) Verfahren zur herstellung von thiophenglycosidderivaten
DE602004001646D1 (de) Verfahren zur Herstellung von Pyran
DE602004012912D1 (de) Verfahren zur Herstellung von Fluorhalogenethern
DE602004005239D1 (de) Verfahren zur herstellung von tubulininhibitoren
DE60301444T2 (de) Verfahren zur Herstellung von Polyalkylphenoxyaminoalkanen
DE602004024152D1 (de) Verfahren zur Herstellung von (Per)fluorhalogenethern
DE502004005103D1 (de) Verfahren zur Herstellung von Acyloxybenzolsulfonaten
DE602004018447D1 (de) Verfahren zur Herstellung von Alkylbenzaldehyden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition